from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2553c/-

LFCtreatmentdescriptionclass of inhibitor

-1.806

Amikacinug/mL Amikacintranslation

-2.239

Cap5-10ug/mL Capreomycintranslation

-3.134

Rox10-50 ug/mL Roxithromycintranslation

0.050

SM2-5 ug/mL Streptomycintranslation

-4.393

Tet5-10 ug/mL Tetracyclinetranslation

-0.766

Rif0.2-5ug/mL Rifampicintranscription

0.100

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.687

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.366

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.969

CPZ10-50 ug/mL Chlorpromazinerespiration

0.759

Clofazimine10-13 ug/mL Clofaziminerespiration

0.198

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.853

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.451

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.016

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.173

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.706

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.049

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.623

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.146

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.561

KCN5-20 ug/mL Potassium cyaniderespiration

0.530

NaN30.2-2 mM Sodium aziderespiration

0.201

Nigericin50 uM Nigericinrespiration

0.092

TRC10-150 ug/mL Triclosanrespiration

-0.451

TRZ10-25 ug/mL Thioridazinerespiration

-0.754

Valinomycin0.5-10 uM Valinomycinrespiration

0.564

ZnSO42 mM ZnSO4respiration

0.099

menadione6-10 ug/mL Menadionerespiration

0.340

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.056

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.076

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.214

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.198

NRP_1Non-replicating persistence stage 1dosRassociated

0.412

Amp0.2mg/mL AmpicillincellWall

0.104

Cephalexin20-100 ug/mL CephalexincellWall

-0.136

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.023

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.024

EMB10-20 ug/mL EthambutolcellWall

-0.001

Eta12-40 ug/mL EthionamidecellWall

0.071

INH0.2-0.4 ug/mL IsoniazidcellWall

0.084

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.387

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.180

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.272

BZA0.12 mg/mL BenzamidearomaticAmides

-0.124

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.080

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.573

H2O24 mM hydrogen peroxideDNAdamaging

-0.423

Levo10 ug/mL LevofloxacinDNAdamaging

-0.110

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.788

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.165

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.304

UVUV-irradiationDNAdamaging

-0.816

ARP41-4 ug/mL Antitubercular compound ARP4?

0.074

Antimycin12.5-50 ug/mL Antimycin A?

0.234

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.113

PA_110-50 ug/mL Antitubercular compound PA-1?

0.216

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.337

PA8240.2-2 ug/mL PA-824?

1.370

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.810

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.295

Verapamil50 uM Verapamil?

-0.019

mercaptoethanol2 mM 2-Mercaptoethanol?

0.258

methoxatin10-20 ug/mL Methoxatin?